AGLE - Aeglea BioTherapeutics GAAP EPS of -$2.27 August, 11 2023 10:25 AM Aeglea BioTherapeutics Inc. 2023-08-11 10:25:25 ET Aeglea BioTherapeutics press release ( NASDAQ: AGLE ): Q2 GAAP EPS of -$2.27. $236.7 million of cash and cash equivalents and restricted cash as of June 30, 2023 For further details see: Aeglea BioTherapeutics GAAP EPS of -$2.27